Balchem's Adjusted EBITDA Falls Slightly in 2017, but We Maintain a Positive Outlook; $85 FVE Intact
Balchem delivered steady results in 2017, as adjusted EBITDA declined slightly to $148 million from $149 million in 2016. Adjusted earnings, however, reached a record level of $2.53 per share, up from $2.52 per share in 2016 and $2.51 per share in 2015. Having updated our valuation model, our $85 per share is unchanged and we view shares as modestly undervalued. Our narrow moat rating is unchanged.For Balchem's flagship human nutrition and health segment, we remain optimistic about increased ch...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.